Back to top
more

IQVIA (IQV)

(Delayed Data from NYSE)

$177.49 USD

177.49
1,651,595

-6.44 (-3.50%)

Updated Aug 6, 2025 04:00 PM ET

After-Market: $177.54 +0.05 (0.03%) 4:44 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (148 out of 246)

Industry: Medical - Instruments

Zacks News

Zacks Equity Research

Here's Why IQVIA Holdings (IQV) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

IQVIA Holdings (IQV) is a Top-Ranked Momentum Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Unlocking Q4 Potential of IQVIA (IQV): Exploring Wall Street Estimates for Key Metrics

Evaluate the expected performance of IQVIA (IQV) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Zacks Equity Research

Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

Will IQVIA (IQV) Beat Estimates Again in Its Next Earnings Report?

IQVIA (IQV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

Penumbra (PEN) Surges 6.3%: Is This an Indication of Further Gains?

Penumbra (PEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Equity Research

IQVIA Benefits From Global IT Infrastructure Amid Low Liquidity

The IQV stock gains from its $330-billion addressable market and an enormous trove of data, which is its distinguishing asset.

Zacks Equity Research

IQVIA (IQV) Surges 3.0%: Is This an Indication of Further Gains?

IQVIA (IQV) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Equity Research

Why You Should Retain IQVIA Holdings Stock in Your Portfolio Now

IQV is known for its innovative use of technology and data analytics.

Zacks Equity Research

Green Dot Stock Appreciates 4% Despite Earnings Miss in Q3

GDOT's third-quarter 2024 revenues increase primarily from the performance of the B2B Services segment.

Zacks Equity Research

Envestnet's Shares Barely Move After Q3 Earnings Beat, Revenues Lag

ENV's top line in the third quarter of 2024 benefits from improved segmental performance.

Zacks Equity Research

MARA Holdings Set to Report Q3 Earnings: What's in the Offing?

The commencement of the Kaspa mining operations is likely to have benefited MARA's top line in the third quarter of 2024.

Zacks Equity Research

Insperity Stock Appreciates 5% After Reporting Q3 Earnings Beat

NSP witnesses a rise in WSEE in the third quarter of 2024.

Zacks Equity Research

Interpreting IQVIA (IQV) International Revenue Trends

Evaluate IQVIA's (IQV) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

Zacks Equity Research

IQVIA (IQV) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for IQVIA (IQV) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

IQVIA Earnings & Revenues Surpass Estimates in Q3, Increase Y/Y

Strength in the Research and Development, and Technology and Analytics segments drives IQV's top line in the third quarter of 2024.

Zacks Equity Research

Veeva Systems Collaborates With Walgreens to Improve Patient Outcomes

VEEV partners with Walgreens to provide better patient outcomes to life sciences companies.

Zacks Equity Research

IQVIA Holdings (IQV) Q3 Earnings and Revenues Beat Estimates

IQVIA (IQV) delivered earnings and revenue surprises of 1.07% and 1.11%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Mark Vickery headshot

Top Research Reports for Apple, Novo Nordisk & RTX

Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Novo Nordisk A/S (NVO) and RTX Corporation (RTX), as well as a micro-cap stock FONAR Corporation (FONR).

Zacks Equity Research

IQVIA Gears Up to Report Q3 Earnings: Here's What You Should Know

IQV's TAS and RD&S revenues are anticipated to have increased, while CSMS revenues are likely to have dipped in the third quarter of 2024.

Zacks Equity Research

Hologic (HOLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Hologic (HOLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Seeking Clues to IQVIA (IQV) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics

Besides Wall Street's top -and-bottom-line estimates for IQVIA (IQV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.

Zacks Equity Research

IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth

IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

EPAM Expands With First Derivative Buyout: What Should Investors Do?

Epam Systems expands its AI capabilities in the financial space with the acquisition of First Derivative.